ARCHIVES

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

This article is from The Cancer Letter archive.

Vol. 24 No. 31 | August 7, 1998

Download PDF Visit The Full Archive

Related Articles

New Genetic Test Approved For Breast Cancer Patients

July 25, 2008

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006